These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21663507)

  • 61. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
    Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
    Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment.
    Eichenauer DA; Hartmann S
    Expert Rev Hematol; 2023; 16(8):607-615. PubMed ID: 37337881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution.
    Kenderian SS; Habermann TM; Macon WR; Ristow KM; Ansell SM; Colgan JP; Johnston PB; Inwards DJ; Markovic SN; Micallef IN; Thompson CA; Porrata LF; Martenson JA; Witzig TE; Nowakowski GS
    Blood; 2016 Apr; 127(16):1960-6. PubMed ID: 26837698
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment results of Hodgkin's lymphoma].
    Aleknavicius E; Valuckas KP; Aleknaviciene B; Norkiene L; Smailyte G
    Medicina (Kaunas); 2009; 45(8):615-23. PubMed ID: 19773620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.
    Karuturi M; Hosing C; Fanale M; Medeiros LJ; Alousi AM; de Lima MJ; Qazilbash MH; Kebriaei P; Younes A; Khouri I; Andersson BS; Champlin R; Anderlini P; Popat U
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):991-4. PubMed ID: 23507470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
    Shankar AG; Roques G; Kirkwood AA; Lambilliotte A; Freund K; Leblanc T; Hayward J; Abbou S; Ramsay AD; Schmitt C; Gorde-Grosjean S; Pacquement H; Haouy S; Boudjemaa S; Aladjidi N; Hall GW; Landman-Parker J
    Br J Haematol; 2017 Apr; 177(1):106-115. PubMed ID: 28220934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N
    J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiple Cavitary Lung Lesions in an Adolescent: Case Report of a Rare Presentation of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Soliman M; Neemuchwala F; Sankar A; Jasty R; Rabah R; Popova AP; Newman EA
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e454-e457. PubMed ID: 30102646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience.
    Eyre TA; Gatter K; Collins GP; Hall GW; Watson C; Hatton CS
    Am J Hematol; 2015 Jun; 90(6):E103-10. PubMed ID: 25715900
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?
    Laskar S; Kumar DP; Khanna N; Menon H; Sengar M; Arora B; Gujral S; Shet T; Sridhar E; Rangarajan V; Muckaden MA; Nair R; Banavali S
    Leuk Lymphoma; 2014 Oct; 55(10):2356-61. PubMed ID: 24354681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
    J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
    Eichenauer DA; Fuchs M
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience.
    Jackson C; Sirohi B; Cunningham D; Horwich A; Thomas K; Wotherspoon A
    Ann Oncol; 2010 Oct; 21(10):2061-2068. PubMed ID: 20332141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
    Fan Z; Natkunam Y; Bair E; Tibshirani R; Warnke RA
    Am J Surg Pathol; 2003 Oct; 27(10):1346-56. PubMed ID: 14508396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
    Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J
    Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263
    [No Abstract]   [Full Text] [Related]  

  • 77. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
    Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
    Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting.
    Fromm JR; Thomas A; Wood BL
    Am J Pathol; 2017 Feb; 187(2):304-317. PubMed ID: 27998726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site.
    Cotta CV; Coleman JF; Li S; Hsi ED
    Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.